Seminar on FDA's GMP Expectations for Phase I and First-in-Man Clinical Trials training seminars presented by Global Compliance Panel register now on FindaSeminar.com

findaseminar logo balls FindaSeminar.com
event search registration and marketing services since 2002
Advanced Search
 
 

** NOTE: All April seminars are live Virtual or Online click to view events.

Seminar on FDA's GMP Expectations for Phase I and First-in-Man Clinical Trials  

 Email information about this seminar Seminar on FDA's GMP Expectations for Phase I and First-in-Man Clinical Trials by Global Compliance Panel to yourself your manager or associates Email this event... View and register for other training seminars like Seminar on FDA's GMP Expectations for Phase I and First-in-Man Clinical Trials by Global Compliance Panel on FindaSeminar.com Find similar training.. Find and register for other training seminars by Global Compliance Panel on FindaSeminar.com Other seminars from Global Compliance Panel

By:

Global Compliance Panel   

For:

Clinial trials officers

Cost:   

see Registration info for seminar cost, group discount etc.

Seminar Summary:

To gain an understanding of the requirements for advancing drugs from research into early clinical development and the minimum FDA requirements for phase I GMPs. To learn practical applications for implementing phase I manufacturing strategies to meet FDA requirements. (see full course description)

 

 Seminar / Training class dates & locations

 

No seminar dates for this event are currently scheduled.  Please use the seminars search box above or choose one of the following additional training search options to find similar training.

gmp+good+manufacturing+practice+drug+addiction+treatment+centers+pharmaceutical+industry+manufacturiers+clinical+research+quality+system+diagram+fda+regulatory+compliance training seminars workshops conferences online training

Providers course catalog

Find seminars by state

Find seminars by city

Request on site training

Use Advanced Search

NEW  Don't miss training you want to attend

Receive a personal Training Alert when training you want to attend comes to your area. Create a personal Training Alert now  it's Free and only takes a minute!


 

 

 

share this page 

print the agenda print agenda for the Seminar on FDA's GMP Expectations for Phase I and First-in-Man Clinical Trials seminar

 

 

Training Course Syllabus:


Course "FDA´s GMP Expectations for Phase I and First-in-Man Clinical Trials" has been pre-approved by RAPS as eligible for up to 12 credits towards a participant´s RAC recertification upon full completion.

Overview:

Early clinical trials are conducted to establish initial safety of a drug. The studies are generally in small number of healthy subjects and use lower doses of the drug product. Therefore, only small amounts of investigational material are required. In order to not undertake substantial costs and to reduce regulatory burden during these early stages, the FDA has established guidelines to allow early stage investigational products to be manufactured under less stringent GMPs.

Why should you attend:

To gain an understanding of the requirements for advancing drugs from research into early clinical development and the minimum FDA requirements for phase I GMPs. To learn practical applications for implementing phase I manufacturing strategies to meet FDA requirements.

Areas Covered in the Session:

Seminar Day 1
The following topics will be discussed to provide the foundation and basis for advancing drugs into clinical development from research and providing required information to the FDA regarding these products.
• Moving a Product out of R&D
• CMC Requirements for an IND Study
• Good Manufacturing Practices: Basics for Beginners
• Raw Material Management

Seminar Day 2
The following topics will be discussed to provide the requirements for early stage products of different types and for vendor selection and management.
• GMPs for Phase 1 IND products
• GMPs for Combination Products and 505(b)(2) Products
• Process Validation for Early Stage GMP
Outsourcing Early Stage Manufacturing

Agenda:

Day 1 Schedule

Lecture 1:
Issues with research grade material used for laboratory and non-clinical testing
Lecture 2:
Optimizing manufacturing processes
Lecture 3:
Raw material requirements and process development
Lecture 4:
Assessing scalability of manufacturing
Lecture 5:
Planning the CMC for a potential IND
Lecture 6:
Study Essential elements of the CMC section of an IND
Lecture 7:
Characterization of the active ingredient and finished product
Lecture 8:
Various kinds of products: drugs, biologics, botanicals, diagnostics, medical devices
Lecture 9:
Manufacturing facility, personnel and equipment requirements
Lecture 10:
Core principles of GMP Regulatory requirements for different products: drugs to medical devices
Lecture 11:
Customizing regulatory compliance to a given product
Lecture 12:
Role of discussions with the FDA
Lecture 13:
Planning for the early stage with an eye towards large scale manufacturing
Lecture 14:
Vendor management
Lecture 15:
Raw material handling issues for early stage products
Lecture 16:
Manufacturing step development


Day 2 Schedule

Lecture 1:
The scope of the FDA guidance document
Lecture 2:
Acceptable practices and practical tips
Lecture 3:
GMP requirements for exploratory clinical studies
Lecture 4:
Specific requirements for drugs, biologics and combination products
Lecture 5:
Specific issues for various kinds of combination products
Lecture 6:
Combination products with one or more new components
Lecture 7:
CMC issues for 505(b)(2) products
Lecture 8:
GMP and QSR: which to follow for a combination products
Lecture 9:
Introduction to process validation for early stage manufacturers
Lecture 10:
Step by step instructions for process validation
Lecture 11:
Process validation reports and other documentation
Lecture 12:
Developing SOPs based on validation processes
Lecture 13:
Logistics of using contract manufacturing organizations for early stage products
Lecture 14:
Pilot scale manufacturing requirements GMP-grade and non-GMP grade manufacturing
Lecture 15:
Benefits and challenges with using local and international vendors

Speaker:

Peggy J. Berry

Peggy J. Berry, MBA, RAC, is the President & CEO at Synergy Consulting where she provides consulting services to companies in all aspects of drug development. She also provides group and one-on-one training in drug development, regulatory affairs and project management topics. Prior to founding Synergy Consulting in 2015, she was Vice President of Regulatory Affairs at Insmed (2/2015-5/2015) where she was responsible for the development and implementation of global regulatory strategies and the management and oversight of the regulatory affairs department.

Seminar Summary:

To gain an understanding of the requirements for advancing drugs from research into early clinical development and the minimum FDA requirements for phase I GMPs. To learn practical applications for implementing phase I manufacturing strategies to meet FDA requirements. (see full course description)

print this agenda print agenda for the Seminar on FDA's GMP Expectations for Phase I and First-in-Man Clinical Trials training seminar

 view dates and locations for this seminar

 

 

 

Custom Search